News

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...
Buy, Sell, Or Hold Pfizer Stock At $23?
Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...
Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives
Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...
Is Pfizer Stock a Buy After This $1.25 Billion Investment?
Pfizer ( PFE 1.46%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the ...
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Pfizer (NYSE:PFE)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Pfizer ...
Hosted on MSN21d
European Court of Justice: Ursula von der Leyen's Pfizer texts must be released to New York Times
"The Commission decision refusing a journalist of The New York Times access to the text messages exchanged between President von der Leyen and the CEO of Pfizer is annulled," the court ruling said.
EU Commission loses on all counts in Pfizergate legal case
The EU’s top court annulled the Commission’s decision to deny the newspaper New York Times access to messages exchanged between President Ursula von der Leyen and Pfizer CEO Albert Bourla, finding ...
UPI21d
ECJ: Ursula von der Leyen's Pfizer texts must be released to New York Times
"The Commission decision refusing a journalist of The New York Times access to the text messages exchanged between President von der Leyen and the CEO of Pfizer is annulled," the court ruling said.